In this context, treatment of colon cancer cells with 5-FU can activate MHC I expression in a p53-dependent manner and increase tumor cell susceptibility to cytotoxic T-lymphocyte-mediated lysis [116,118]. The gene discussed is TP53; the disease is neoplasm.